Glucagon is usually thought of as a glucose- raising hormone, but in the context of simultaneous GLP-1/GIP agonism the net effect studied in trials was increased energy expenditure alongside strong glycemic control a combination that appears to explain the outsized weight effect observed in the research
These glucagon-like peptide-1 (GLP-1) medications were first used to treat type 2 diabetes and obesity
All weight loss clients receive member pricing on all services in the clinic
The regulatory landscape and what it means for dosing The availability and dosage charts of these compounds are tied to their regulatory status, and that status affects everything from access to quality to clinical support
Melanotan 2 is a generalist: it activates MC1, MC3, MC4, and MC5, making it a tool for studying melanogenesis via the MC1R, but with a broad signature
This is not harmful in most cases